Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Endoscopy

Volumn 48, Issue 9, 2016, Pages 843-864

  Bisschops, Raf ^a   Areia, Miguel ^b,c   Coron, Emmanuel ^d   Dobru, Daniela ^e   Kaskas, Bernd ^f   Kuvaev, Roman ^g   Pech, Oliver ^h   Ragunath, Krish ⁱ   Weusten, Bas ^j   Familiari, Pietro ^k   Domagk, Dirk ^l   Valori, Roland ^m   Kaminski, Michal F ^n,o   Spada, Cristiano ^k   Bretthauer, Michael ^n,p   Bennett, Cathy ^q   Senore, Carlo ^r   Dinis Ribeiro, Mário ^c,s   Rutter, Matthew D ^t,u  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c University of Porto   (Portugal)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g Yaroslavl Regional Children's Hospital   (Russian Federation)

^h Barmherzige Bruder Regensburg   (Germany)

ⁱ QUEEN S MEDICAL CENTRE   (United Kingdom)

^j ST ANTONIUS HOSPITAL   (Netherlands)

^k FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^l Joseph's Hospital   (Germany)

^m GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁿ UNIVERSITY OF OSLO   (Norway)

^o MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

^q Faculty of Health and Life Sciences   (United Kingdom)

^r CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^s PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^t UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^u DURHAM UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; EVIDENCE BASED PRACTICE; GASTROINTESTINAL ENDOSCOPY; HUMAN; PATHOLOGY; PERFORMANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESEARCH PRIORITY; REVIEW; TOTAL QUALITY MANAGEMENT; CONSENSUS DEVELOPMENT; DELPHI STUDY; HEALTH CARE QUALITY; STANDARDS;

DELPHI TECHNIQUE; ENDOSCOPY, GASTROINTESTINAL; HUMANS; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE;

EID: 84983428073     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0042-113128     Document Type: Review

References (146)

1. Rutter M. D., Senore C., Bisschops R. et al. The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy: 2016; 48 81 89
2. Kaminski M. F., Regula J., Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. NEJM: 2010; 362 1795 1803
3. Barclay R. L., Vicari J. J., Doughty A. S. et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEJM: 2006; 355 2533 2541
4. Bennett C., Moayyedi P., Corley D. A. et al. BOB CAT: A large-scale review and Delphi consensus for management of Barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol: 2015; 110 662 682; quiz 683
5. Bennett C., Vakil N., Bergman J. et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology: 2012; 143 336 346
6. Guyatt G. H., Oxman A. D., Vist G. E. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ: 2008; 336 924 926
7. Koeppe A., Lubini M., Bonadeo N. et al. Comfort, safety and quality of upper gastrointestinal endoscopy after 2 hours fasting: a randomized controlled trial. BMC Gastroenterol: 2013; 13 158
8. De Silva A. P., Amarasiri L., Liyanage M. N. et al. One-hour fast for water and six-hour fast for solids prior to endoscopy provides good endoscopic vision and results in minimum patient discomfort. J Gastroenterol Hepatol: 2009; 24 1095 1097
9. Teh J. L., Tan J. R., Lau L. JF et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol: 2015; 13 480 487.e2
10. Gupta N., Gaddam S., Wani S. B. et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc: 2012; 76 531 538
11. Park C. H., Kim B., Chung H. et al. Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. Dig Dis Sci: 2015; 60 38 46
12. Rey J. F., Lambert R. ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy: 2001; 33 901 903
13. Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol Q Publ Hell Soc Gastroenterol: 2013; 26 11 22
14. Bretthauer M., Aabakken L., Dekker E. et al. Requirements and standards facilitating quality improvement for reporting systems in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy: 2016; 48 291 294
15. Armstrong D., Bennett J. R., Blum A. L. et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology: 1996; 111 85 92
16. Lundell L. R., Dent J., Bennett J. R. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut: 1999; 45 172 180
17. Armstrong D. Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia. Aliment Pharmacol Ther: 2004; 20 40 47; discussion 61-62
18. Sharma P., Dent J., Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology: 2006; 131 1392 1399
19. Barclay R. L., Vicari J. J., Greenlaw R. L. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol: 2008; 6 1091 1098
20. Dinis-Ribeiro M., Areia M., de Vries A. C. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa. Endoscopy: 2012; 44 74 94
21. Areia M., Dinis-Ribeiro M., Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter: 2014; 19 425 436
22. Lambert R., Lightdale C. J. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon - November 30 to December 1, 2002. Gastrointest Endosc: 2003; 58 S3 S4
23. Axon A., Diebold M. D., Fujino M. et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy: 2005; 37 570 578
24. van Doorn S. C., Hazewinkel Y., East J. E. et al. Polyp morphology: an interobserver evaluation for the Paris classification among international experts. Am J Gastroenterol: 2015; 110 180 187
25. Armstrong D., Bennett J. R., Blum A. L. et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology: 1996; 111 85 92
26. Pandolfino J. E., Vakil N. B., Kahrilas P. J. Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists. Gastrointest Endosc: 2002; 56 639 643
27. Vahabzadeh B., Seetharam A. B., Cook M. B. et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc: 2012; 75 236 241
28. Alvarez Herrero L., Curvers W. L., van Vilsteren F. GI et al. Validation of the Prague C&M classification of Barrett's esophagus in clinical practice. Endoscopy: 2013; 45 876 882
29. Forrest J. A., Finlayson N. D., Shearman D. J. Endoscopy in gastrointestinal bleeding. Lancet: 1974; 2 394 397
30. De Groot N. L., Van Oijen M. GH, Kessels K. et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: Can classification be simplified? Endoscopy: 2014; 46 46 52
31. Gralnek I., Dumonceau J-M, Kuipers E. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy: 2015; 47 a1 a46
32. Cheng H-T, Cheng C-L, Lin C-H et al. Caustic ingestion in adults: the role of endoscopic classification in predicting outcome. BMC Gastroenterol: 2008; 8 31
33. LaBrecque D., Khan A. G., Sarin S. K. et al. Esophageal Varices. World Gastroenterology Organisation Global Guidelines 2014. Available from: http://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-english-2014.pdf. Accessed 2016 July 4
34. de Franchis R., Baveno V. Faculty Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol: 2010; 53 762 768
35. Spigelman A. D., Williams C. B., Talbot I. C. et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet: 1989; 2 783 785
36. Syngal S., Brand R. E., Church J. M. et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol: 2015; 110 223 262; quiz 263
37. Bennett C., Moayyedi P., Corley D. A. et al. BOB CAT: A large-scale review and Delphi consensus for management of Barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol: 2015; 110 662 682; quiz 683
38. Fitzgerald R. C., di Pietro M., Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut: 2014; 63 7 42
39. Tincani A. J., Brandalise N., Altemani A. et al. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer. Head Neck: 2000; 22 170 174
40. Hashimoto C. L., Iriya K., Baba E. R. et al. Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol: 2005; 100 275 282
41. Dubuc J., Legoux J-L, Winnock M. et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy: 2006; 38 690 695
42. Boller D., Spieler P., Schoenegg R. et al. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Surg Endosc: 2009; 23 2748 2754
43. Carvalho R., Areia M., Brito D. et al. Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer. Rev Esp Enferm Dig: 2013; 105 79 83
44. Komínek P., Vítek P., Urban O. et al. Chromoendoscopy to detect early synchronous second primary esophageal carcinoma in patients with squamous cell carcinomas of the head and neck? Gastroenterol Res Pract: 2013; 2013 236264
45. Ina H., Shibuya H., Ohashi I. et al. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer: 1994; 73 2038 2041
46. Shiozaki H., Tahara H., Kobayashi K. et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer: 1990; 66 2068 2071
47. Reid B. J., Blount P. L., Feng Z. et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol: 2000; 95 3089 3096
48. Spechler S. J., Sharma P., Souza R. F. et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology: 2011; 140 1084 1091
49. Abela J. E., Going J. J., Mackenzie J. F. et al. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol: 2008; 103 850 855
50. Peters F. P., Curvers W. L., Rosmolen W. D. et al. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: Nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus: 2008; 21 475 479
51. Kariv R., Plesec T. P., Goldblum J. R. et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol: 2009; 7 653 658
52. Rugge M., Meggio A., Pennelli G. et al. Gastritis staging in clinical practice: the OLGA staging system. Gut: 2007; 56 631 636
53. Capelle L. G., de Vries A. C., Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc: 2010; 71 1150 1158
54. de Vries A. C., Haringsma J., de Vries R. A. et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter: 2010; 15 259 264
55. Guarner J., Herrera-Goepfert R., Mohar A. et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol: 2003; 34 28 31
56. Eriksson N. K., Färkkilä M. A., Voutilainen M. E. et al. The clinical value of taking routine biopsies from the incisura angularis during gastroscopy. Endoscopy: 2005; 37 532 536
57. El-Zimaity H. M., Graham D. Y. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol: 1999; 30 72 77
58. Isajevs S., Liepniece-Karele I., Janciauskas D. et al. The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. Eur J Gastroenterol Hepatol: 2014; 26 510 513
59. Stolte M., Müller H., Talley N. J. et al. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract: 2006; 202 405 413
60. Cabrera Chamorro C., Méndez Manchola C., Molina Ramírez I. et al. [Endoscopic balloon dilatation of esophageal strictures in children]. Cir Pediatr: 2013; 26 106 111
61. Caro L., Sánchez C., Rodríguez P. et al. Endoscopic balloon dilation of anastomotic strictures occurring after laparoscopic gastric bypass for morbid obesity. Dig Dis: 2008; 26 314 317
62. Contini S., Garatti M., Swarray-Deen A. et al. Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation. Dig Liver Dis: 2009; 41 263 268
63. Contini S., Tesfaye M., Picone P. et al. Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone. Int J Pediatr Otorhinolaryngol: 2007; 71 1597 1604
64. Dellon E. S., Gibbs W. B., Rubinas T. C. et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc: 2010; 71 706 712
65. Fry L. C., Mönkemüller K., Neumann H. et al. Incidence, clinical management and outcomes of esophageal perforations after endoscopic dilatation. Zeitschrift für Gastroenterol: 2007; 45 1180 1184
66. Hagel A. F., Naegel A., Dauth W. et al. Perforation during esophageal dilatation: a 10-year experience. J Gastrointestin Liver Dis: 2013; 22 385 389
67. Jayakrishnan V. K., Wilkinson A. G. Treatment of oesophageal strictures in children: a comparison of fluoroscopically guided balloon dilatation with surgical bouginage. Pediatr Radiol: 2001; 31 98 101
68. Ko H-K, Shin J. H., Song H-Y et al. Balloon dilation of anastomotic strictures secondary to surgical repair of esophageal atresia in a pediatric population: long-term results. J Vasc Interv Radiol: 2006; 17 1327 1333
69. Laín A., Cerdá J., Cañizo A. et al. [Analysis of esophageal strictures secondary to surgical correction of esophageal atresia]. Cir Pediatr: 2007; 20 203 208
70. Lakhdar-Idrissi M., Khabbache K., Hida M. Esophageal endoscopic dilations. J Pediatr Gastroenterol Nutr: 2012; 54 744 747
71. Lan L. CL, Wong K. KY, Lin S. CL et al. Endoscopic balloon dilatation of esophageal strictures in infants and children: 17 years' experience and a literature review. J Pediatr Surg: 2003; 38 1712 1715
72. Lang T., Hümmer H. P., Behrens R. Balloon dilation is preferable to bougienage in children with esophageal atresia. Endoscopy: 2001; 33 329 335
73. Lian J. J., Ma L. L., Hu J. W. et al. Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms. J Dig Dis: 2014; 15 224 229
74. Na H. K., Choi K. D., Ahn J. Y. et al. Outcomes of balloon dilation for the treatment of strictures after endoscopic submucosal dissection compared with peptic strictures. Surg Endosc: 2013; 27 3237 3246
75. Poddar U., Thapa B. R. Benign esophageal strictures in infants and children: results of Savary-Gilliard bougie dilation in 107 Indian children. Gastrointest Endosc: 2001; 54 480 484
76. Qureshi S., Ghazanfar S., Leghari A. et al. Benign esophageal strictures: behaviour, pattern and response to dilatation. J Pak Med Assoc: 2010; 60 656 660
77. Rana S. S., Bhasin D. K., Chandail V. S. et al. Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc: 2011; 25 1579 1584
78. Raymondi R., Pereira-Lima J. C., Valves A. et al. Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology: 2008; 55 1342 1348
79. Romeo E., Foschia F., de Angelis P. et al. Endoscopic management of congenital esophageal stenosis. J Pediatr Surg: 2011; 46 838 841
80. Said M., Mekki M., Golli M. et al. Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia. Br J Radiol: 2003; 76 26 31
81. Shehata S. MK, Enaba M. E. Endoscopic dilatation for benign oesophageal strictures in infants and toddlers: experience of an expectant protocol from North African tertiary centre. Afr J Paediatr Surg: 2012; 9 187 192
82. Thyoka M., Barnacle A., Chippington S. et al. Fluoroscopic balloon dilation of esophageal atresia anastomotic strictures in children and young adults: single-center study of 103 consecutive patients from 1999 to 2011. Radiology: 2014; 271 596 601
83. Ukleja A., Shiroky J., Agarwal A. et al. Esophageal dilations in eosinophilic esophagitis: a single center experience. World J Gastroenterol: 2014; 20 9549 9555
84. Uygun I., Arslan M. S., Aydogdu B. et al. Fluoroscopic balloon dilatation for caustic esophageal stricture in children: an 8-year experience. J Pediatr Surg: 2013; 48 2230 2234
85. Weintraub J. L., Eubig J. Balloon catheter dilatation of benign esophageal strictures in children. J Vasc Interv Radiol: 2006; 17 831 835
86. Yeming W., Somme S., Chenren S. et al. Balloon catheter dilatation in children with congenital and acquired esophageal anomalies. J Pediatr Surg: 2002; 37 398 402
87. Yoda Y., Yano T., Kaneko K. et al. Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc: 2012; 26 2877 2883
88. Albéniz-Arbizu E., Pueyo-Royo A., Eguaras-Ros J. et al. Endoscopic mucosal resection for proximal superficial lesions: efficacy and safety study in 59 consecutive resections. Rev Esp Enferm Dig: 2012; 104 458 467
89. Alexander S., Bourke M. J., Williams S. J. et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc: 2009; 69 66 73
90. Basford P. J., George R., Nixon E. et al. Endoscopic resection of sporadic duodenal adenomas: comparison of endoscopic mucosal resection (EMR) with hybrid endoscopic submucosal dissection (ESD) techniques and the risks of late delayed bleeding. Surg Endosc: 2014; 28 1594 1600
91. Binmoeller K. F., Shah J. N., Bhat Y. M. et al. Underwater EMR of sporadic laterally spreading nonampullary duodenal adenomas (with video). Gastrointest Endosc: 2013; 78 496 502
92. Conio M., De Ceglie A., Filiberti R. et al. Cap-assisted EMR of large, sporadic, nonampullary duodenal polyps. Gastrointest Endosc: 2012; 76 1160 1169
93. Conio M., Fisher D. A., Blanchi S. et al. One-step circumferential endoscopic mucosal cap resection of Barrett's esophagus with early neoplasia. Clin Res Hepatol Gastroenterol: 2014; 38 81 91
94. Fanning S. B., Bourke M. J., Williams S. J. et al. Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats. Gastrointest Endosc: 2012; 75 805 812
95. Huntington J. T., Walker J. P., Meara M. P. et al. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc: 2015; 29 2121 2125
96. Inoue T., Uedo N., Yamashina T. et al. Delayed perforation: a hazardous complication of endoscopic resection for non-ampullary duodenal neoplasm. Dig Endosc: 2014; 26 220 227
97. Kakushima N., Ono H., Takao T. et al. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors. Dig Endosc: 2014; 26 02 35 40
98. Kim G. H., Kim J. I., Jeon S. W. et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol: 2014; 29 318 324
99. Kim H-K, Chung W. C., Lee B-I et al. Efficacy and long-term outcome of endoscopic treatment of sporadic nonampullary duodenal adenoma. Gut Liver: 2010; 4 373 377
100. Konda V. JA, Gonzalez Haba Ruiz M., Koons A. et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol: 2014; 12 2002 2010.e1-e2
101. Lee K. J., Kim G. H., Park D. Y. et al. Endoscopic resection of gastrointestinal lipomas: a single-center experience. Surg Endosc: 2014; 28 185 192
102. Li N., Pasricha S., Bulsiewicz W. J. et al. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus: 2015; Epub ahead of print
103. Makazu M., Kato K., Takisawa H. et al. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Dis Esophagus: 2014; 27 42 49
104. Matsumoto S., Yoshida Y. Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience. World J Gastroenterol: 2014; 20 8624 8630
105. Min B-H, Kim E. R., Lee J. H. et al. Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion: 2013; 87 247 253
106. Min Y. W., Min B-H, Kim E. R. et al. Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci: 2013; 58 2926 2932
107. Navaneethan U., Lourdusamy D., Mehta D. et al. Endoscopic resection of large sporadic non-ampullary duodenal polyps: efficacy and long-term recurrence. Surg Endosc: 2014; 28 2616 2622
108. Nonaka S., Oda I., Tada K. et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy: 2015; 47 129 135
109. Oka S., Tanaka S., Higashiyama M. et al. Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes. Surg Endosc: 2014; 28 639 647
110. Oka S., Tanaka S., Nagata S. et al. Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol: 2003; 37 381 386
111. Park S. M., Ham J. H., Kim B-W et al. Feasibility of endoscopic resection for sessile nonampullary duodenal tumors: a multicenter retrospective study. Gastroenterol Res Pract: 2015; 2015 692492
112. Pimentel-Nunes P., Mourão F., Veloso N. et al. Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy: 2014; 46 933 940
113. Qumseya B., David W., Woodward T. A. et al. Safety of esophageal EMR in elderly patients. Gastrointest Endosc: 2014; 80 586 591
114. Seo J. Y., Hong S. J., Han J. P. et al. Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma. J Gastroenterol Hepatol: 2014; 29 1692 1698
115. Sohn J. W., Jeon S. W., Cho C. M. et al. Endoscopic resection of duodenal neoplasms: a single-center study. Surg Endosc: 2010; 24 3195 3200
116. Uygun A., Kadayifci A., Polat Z. et al. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. J Surg Oncol: 2014; 109 71 74
117. Yamamoto Y., Yoshizawa N., Tomida H. et al. Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor. Dig Endosc: 2014; 26 02 50 56
118. Zhong Y-S, Shi Q., Wu H-F et al. Endoscopic resection for the treatment of duodenal Brunner's adenomas. J Laparoendosc Adv Surg Tech A: 2012; 22 904 909
119. van Zuuren F. J., Grypdonck M., Crevits E. et al. The effect of an information brochure on patients undergoing gastrointestinal endoscopy: a randomized controlled study. Patient Educ Couns: 2006; 64 173 182
120. Ajumobi A., Bahjri K., Jackson C. et al. Surveillance in Barrett's esophagus: An audit of practice. Dig Dis Sci: 2010; 55 1615 1621
121. Bansal A., Mcgregor D. H., Anand O. et al. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus. Dis Esophagus: 2014; 27 751 756
122. Basu K. K., Pick B., de Caestecker J. S. Audit of a Barrett's epithelium surveillance database. Eur J Gastroenterol Hepatol: 2004; 16 171 175
123. Bertani H., Frazzoni M., Dabizzi E. et al. Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program. Dig Dis Sci: 2013; 58 188 193
124. Canto M. IF, Setrakian S., Willis J. et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc: 2000; 51 560 568
125. Conio M., Blanchi S., Lapertosa G. et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol: 2003; 98 1931 1939
126. Egger K., Werner M., Meining A. et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut: 2003; 52 18 23
127. Gladman L., Chapman W., Iqbal T. H. et al. Barrett's oesophagus: an audit of surveillance over a 17-year period. Eur J Gastroenterol Hepatol: 2006; 18 271 276
128. Gopal D. V., Lieberman D. A., Magaret N. et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): Results from a multicenter consortium. Dig Dis Sci: 2003; 48 1537 1541
129. de Jonge P. J., van Blankenstein M., Looman C. W. et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut: 2010; 59 1030 1036
130. Sharma P., Hawes R. H., Bansal A. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut: 2013; 62 15 21
131. Hillman L. C., Chiragakis L., Clarke A. C. et al. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma. J Gastroenterol Hepatol: 2003; 18 526 533
132. Hurschler D., Borovicka J., Neuweiler J. et al. Increased detection rates for Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss Med Wkly: 2003; 133 507 514
133. Komanduri S., Swanson G., Keefer L. et al. Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies. Gastrointest Endosc: 2009; 70 1072 1078.e1
134. Macdonald C. E., Wicks A. C., Playford R. J. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: Observational study. BMJ: 2000; 321 1252 1255
135. Murphy S. J., Dickey W., Hughes D. et al. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland. Eur J Gastroenterol Hepatol: 2005; 17 1029 1035
136. Oberg S., Wenner J., Johansson J. et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg: 2005; 242 49 54
137. Olithselvan A., Gorard D. A., McIntyre A. S. A surveillance programme for Barrett's oesophagus in a UK general hospital. Eur J Gastroenterol Hepatol: 2007; 19 305 309
138. Pohl J., Pech O., May A. et al. Incidence of macroscopically occult neoplasias in Barrett's esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol: 2010; 105 2350 2356
139. Ramus J. R., Gatenby P. A., Caygill C. PJ et al. Surveillance of Barrett's columnar-lined oesophagus in the UK: endoscopic intervals and frequency of detection of dysplasia. Eur J Gastroenterol Hepatol: 2009; 21 636 641
140. Rudolph R. E., Vaughan T. L., Storer B. E. et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med: 2000; 132 612 620
141. Rugge M., Zaninotto G., Parente P. et al. Barrettes esophagus and Adenocarcinoma Risk. Ann Surg: 2012; 256 788 795
142. Sharma P., Weston A. P., Topalovski M. et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut: 2003; 52 24 27
143. Sharma P., Bansal A., Mathur S. et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc: 2006; 64 167 175
144. Terry N. G., Zhu Y., Rinehart M. T. et al. Detection of dysplasia in barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology: 2011; 140 42 50
145. Wani S., Falk G., Hall M. et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol: 2011; 9 220 227.e1
146. Wong T., Tian J., Nagar A. B. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Am J Med: 2010; 123 462 427